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Abstract	
	
Approximately	 50%	of	 ankle	 fractures	 require	 internal	 fixation.	 A	 tourniquet	 is	 often	
employed	to	create	a	bloodless	operative	 field,	but	 its	effect	on	hospital	 length	of	stay	
(LOS)	is	unclear.	This	paper	reports	a	parallel‐group	observer‐blinded	randomized	trial	
of	the	effect	of	tourniquet	use	on	LOS.	188	adult	patients	requiring	internal	fixation	of	
ankle	fracture	were	randomized	to	surgery	with	or	without	tourniquet.	LOS	was	analyzed	
on	 intention‐to‐treat	 principles	 using	 Poisson	 regression.	 As	 a	 secondary	 outcome,	
duration	of	operation	was	analyzed	by	ANCOVA.	Mean	LOS	was	1.79	±1.50	days	in	the	
tourniquet	group	and	1.65	±1.11	days	in	the	no‐tourniquet	group.	The	covariate‐adjusted	
rate	ratio	for	LOS	(reference	group:	no	tourniquet)	was	1.084	(95%	CI	0.871,	1.348;	p	=	
.470).	 Sensitivity	 analyses	 (unadjusted	 intention‐to‐treat	 analysis	 and	 as‐treated	
analysis)	gave	similar	non‐significant	results.	The	covariate‐adjusted	mean	difference	in	
duration	of	 operation	was	3.03	minutes	 (95%	CI	 –4.96,	11.02;	p	 =	 .455),	 favoring	 the	
tourniquet	group;	sensitivity	analyses	again	gave	similar	results.	Adverse	events	did	not	
differ	significantly	between	groups.	In	conclusion,	the	use	of	a	tourniquet	during	internal	
fixation	 does	 not	 significantly	 influence	 hospital	 LOS,	 of	 which	 pre‐injury	 medical	
condition	of	the	patient	appears	to	be	the	most	important	determinant.		
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Introduction	
Ankle	fractures	are	common	injuries,	accounting	for	approximately	9%	of	all	 fractures	
and	 occuring	 at	 a	 rate	 of	 187/100,000	 people	 each	 year	 [1].	 This	 equates	 to	 roughly	
121,000	 ankle	 fractures	 in	 the	 UK	 each	 year.	 Approximately	 half	 are	 deemed	 to	 be	
unstable	 and	 subsequently	 require	 operative	 fixation.	 Operative	 management	 is	
commonly	 carried	 out	 using	 a	 tourniquet	 to	 create	 a	 bloodless	 field	 [2];	 however,	
tourniquet	use	during	lower‐limb	surgery	has	been	associated	with	a	range	of	adverse	
events,	including	vascular	injury,	post‐operative	swelling,	joint	stiffness,	increased	post‐
operative	pain,	neurapraxia,	increased	risk	of	infection	and	deep	vein	thrombosis	[3,4].	
In	a	recent	systematic	review	of	four	studies,	tourniquet	use	in	foot	and	ankle	surgery	
was	also	shown	to	lead	to	an	increased	length	of	hospital	stay	[5].	
If	the	use	of	a	tourniquet	delays	recovery	following	fixation	of	ankle	fracture,	this	will	be	
evidenced	 by	 a	 longer	 hospital	 stay,	 as	 previously	 reported	 [6,7].	 Accordingly,	 the	
objective	 of	 this	 multi‐centre,	 parallel‐group	 randomised	 study	 was	 to	 determine	
whether	the	use	of	a	tourniquet	during	surgery	for	patients	with	closed	ankle	fractures	
affected	the	hospital	LOS.		
	
Patients	and	methods	
Recruitment	and	Randomization	
Adult	patients	with	closed	ankle	fractures	were	invited	to	take	part	in	a	randomized	trial	
of	tourniquet	versus	no	tourniquet	use	for	the	operative	management	of	ankle	fractures.	
Patients	were	 recruited	 from	 the	University	Hospital	of	North	Midlands	 (UHNM)	NHS	
trust,	 Cambridge	 University	 Hospitals	 NHS	 Trust,	 and	 the	 Princess	 Royal	 Hospital,	
Telford,	between	2012	and	2016.	In	total	471	patients	were	assessed	for	eligibility,	and	
188	were	subsequently	recruited	and	randomized.	
Eligible	patients	were	skeletally	mature	adults	(≥18	years)	with	an	isolated,	displaced,	
closed	ankle	fracture	(Weber	classification	A,	B	or	C),	for	whom	an	operative	procedure	
(rather	 than	conservative	 treatment)	was	 indicated.	Exclusions	 included	patients	with	
open	 fractures,	 pilon	 fractures,	 previously	 malunited	 fractures,	 peripheral	 vascular	
disease	 precluding	 tourniquet	 use,	 and	 patients	 with	 bilateral	 fractures	 or	 multiple	
injuries.	 Patients	who	were	 not	 ambulatory	 prior	 to	 the	 fracture,	 unable	 to	 complete	
questionnaires,	or	with	a	language	barrier	that	could	not	be	overcome	through	hospital	
translation	services	were	also	excluded.		
Eligible	 patients	 were	 identified	 on	 admission	 and,	 following	 plain	 radiographs	 to	
confirm	the	fracture	type,	were	given	a	study	information	sheet	and	invited	to	participate	
in	the	trial.	A	research	nurse	or	a	research‐trained	registrar	obtained	written	informed	
consent,	checking	that	the	patient	understood	what	the	study	involves	and	providing	the	
opportunity	to	ask	questions.	Patients	were	then	allocated	to	tourniquet	or	no	tourniquet	
in	 a	 1:1	 ratio	 using	 an	 online	 third‐party	 computerized	 randomization	 service	 at	 the	
University	of	York.	Randomization	was	stratified	by	age	(18–50,	over	50),	using	randomly	
permuted	blocks	of	4	and	6.		
Fracture	 type	was	 classified	according	 to	 the	Weber	 classification	 [8].	Weber	grade	A	
indicates	a	fracture	below	the	talar	dome,	grade	B	denotes	a	fracture	of	the	distal	fibula	
at	the	level	of	the	tibiofibular	syndesmosis,	and	grade	C	indicates	a	fracture	of	the	distal	
fibula	 proximal	 to	 the	 tibiofibular	 syndesmosis.	 Additionally,	 patients	 were	 classified	
prior	to	surgery	using	the	American	Society	of	Anesthesiologists	(ASA)	physical	status	
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system	 [9].	Grade	 I	on	 the	 classification	 indicates	a	normal	healthy	patient,	 grade	 II	 a	
patient	with	mild	systemic	disease,	and	grade	III	a	patient	with	severe	systemic	disease.	
The	Olerud	Molander	Ankle	Scale	(OMAS)	score	was	also	recorded	[10].	
Interventions	
The	timing	of	surgery	was	determined	by	the	soft	tissue	swelling.	Whenever	possible,	the	
operation	occurred	within	24	hours	of	injury,	but	if	the	tissues	were	too	swollen	surgery	
was	delayed	until	 swelling	had	subsided	sufficiently.	Operative	details	were	recorded,	
including	duration	of	operation	and	tourniquet	time.	At	surgery,	the	patient	was	placed	
supine	 with	 a	 sandbag	 under	 the	 buttock	 of	 the	 affected	 side.	 For	 those	 patients	
randomized	 to	 have	 a	 tourniquet,	 this	 was	 applied	 above	 the	 knee	 and	 the	 leg	 was	
prepared,	 draped	 and	 elevated	 before	 tourniquet	 inflation.	 For	 all	 patients,	 fibular	
fixation	was	by	plate	and	screws	via	a	lateral	incision,	following	reduction	of	the	fracture;	
medial	 fixation	was	 then	undertaken	 if	 required.	Wounds	were	 closed	and	a	dressing	
applied.	A	plaster	backslab	was	applied	to	all	patients	to	maintain	90°	ankle	dorsiflexion	
and	the	tourniquet	(if	used)	was	deflated.	The	patient	stayed	in	hospital	until	assessed	as	
clinically	fit	for	discharge.	Patients	returned	home	with	walking	aids	in	the	backslab.	Two	
weeks	 post‐operation,	 patients	 returned	 to	 the	 outpatient	 clinic	 to	 have	 the	 wound	
checked	and	stitches	removed.		
Any	serious	adverse	events	were	recorded	and	appropriate	action	taken	in	accordance	
with	GCP	guidelines	[11].	Data	on	hospital	LOS,	operation	duration	and	intraoperative	or	
immediate	 post‐operative	 complications	 were	 collected	 or	 verified	 from	 patients’	
records.	Authors	HM	and	DM	were	among	the	participating	surgeons.	
Blinding	
Operating	 staff	were	necessarily	 aware	 of	whether	 or	 not	 a	 tourniquet	was	used,	 but	
patients	were	 not	 told	 until	 after	 the	 study.	 For	 determination	 of	 LOS,	 patients	were	
assessed	 for	discharge	home	by	a	clinician	blinded	 to	 tourniquet	allocation.	Statistical	
analysis	was	blind	to	treatment	group	allocation.		
Outcome	measures	
The	primary	outcome	measure,	LOS,	was	defined	as	the	number	of	days	post‐operatively	
that	a	patient	stayed	in	hospital	before	being	considered	clinically	fit	for	discharge,	rather	
than	when	the	patient	actually	left	hospital.	Patients	fit	for	discharge	on	the	same	day	as	
surgery	were	ascribed	a	LOS	of	zero.	Patients	were	assessed	daily	and	the	decision	on	
fitness	 to	 go	 home	 was	 taken	 by	 at	 least	 one	 clinician	 not	 involved	 in	 the	 surgery.	
Secondary	outcomes	were	the	duration	of	the	operative	procedure	and	the	occurrence	of	
intraoperative	or	immediate	postoperative	adverse	events.	
Sample	size	
The	sample	size	was	calculated	based	on	prior	data	showing	a	mean	LOS	(time	until	fit	
for	discharge)	of	4.38	days,	with	a	standard	deviation	(SD)	of	2.72,	for	patients	having	
ankle	fracture	surgery.	These	data	showed	LOS	to	be	only	moderately	positively	skewed.	
A	difference	in	LOS	of	1.5	days	or	greater	was	considered	to	be	important.	In	view	of	the	
tendency	for	preliminary	data	to	underestimate	the	SD	in	the	main	trial	[12],	the	observed	
SD	was	inflated	by	15%	to	3.13.	Accordingly,	to	detect	a	1.5‐day	reduction	in	mean	LOS	
with	90%	power	at	a	5%	2‐sided	significance	level,	data	from	a	minimum	of	93	patients	
in	each	comparison	group	were	required	(186	in	total).	
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Statistical	analysis	
The	primary	analysis	followed	intention‐to‐treat	(ITT)	principles	and	was	in	accordance	
with	 a	 predetermined	 statistical	 analysis	 plan.	 The	 assumptions	 of	 statistical	 models	
were	 checked	 prior	 to	 analysis.	 As	 the	 distribution	 of	 residuals	 did	 not	 meet	 the	
assumptions	 of	 linear	 regression,	 LOS	 was	 compared	 between	 groups	 using	 Poisson	
regression,	adjusting	for	Weber	classification,	ASA	grade,	sex,	BMI,	treatment	center,	and	
time	from	fracture	to	surgery,	and	including	the	stratification	factor	(age)	in	the	model;	
these	 covariates	 were	 determined	 a	 priori.	 The	 duration	 of	 the	 operation,	 for	 those	
patients	who	underwent	surgery,	was	analyzed	by	analysis	of	covariance,	adjusting	for	
the	same	covariates.	Prior	to	conducting	adjusted	analyses,	any	missing	baseline	values	
were	imputed,	following	recent	recommendations	[13].	
An	unadjusted	ITT	analysis	and	an	‘as	treated’	analysis,	whereby	patients	were	analyzed	
according	to	the	intervention	actually	received,	were	carried	out	as	sensitivity	analyses	
[14].	 Subgroup	estimates	of	differences	 in	LOS	between	 tourniquet	and	no	 tourniquet	
were	calculated	for	subgroups	defined	by	sex,	age	(18–50,	over	50),	Weber	classification	
(B,	C)	and	ASA	classification	(I,	II,	III).	These	subgroup	analyses	were	exploratory	and	no	
formal	statistical	testing	was	performed.		
Statistical	significance	was	set	at	p	≤	.05	(2‐tailed),	and	95%	confidence	intervals	(CIs)	
were	calculated	for	between‐group	estimates.	Analysis	was	conducted	in	SPSS	version	
23.	
Ethical	approval	
Ethical	 approval	 for	 the	 study	 was	 obtained	 from	 Staffordshire	 Research	 Ethics	
Committee	(Ref	11/WM/0420),	after	a	full	review.	
	
Results	
The	progression	of	patients	through	the	trial	is	shown	in	a	CONSORT	diagram	(Figure	1).	
Between	 August	 2012	 and	 August	 2015,	 a	 total	 of	 471	 patients	 were	 screened	 for	
eligibility,	 of	 which	 188	 were	 subsequently	 randomized.	 Of	 those	 randomized	 to	
tourniquet,	3	had	surgery	without	a	tourniquet	(clinical	decision	n	=	2;	randomization	
missed	n	=	1)	and	3	did	not	have	surgery.	Of	those	randomized	to	no	tourniquet,	19	had	
surgery	with	a	tourniquet	(clinical	decision	n	=	7;	randomization	missed	n	=	10;	other	
reason	n	=	2),	and	one	did	not	have	surgery.	Following	ITT	principles,	all	patients	were	
entered	in	the	analysis.	
Patients’	baseline	characteristics	are	shown	in	Table	1.	All	variables	were	well	balanced	
across	 the	 groups,	 except	 that	 there	was	 a	 slightly	 higher	 percentage	 of	males	 in	 the	
tourniquet	group	and	some	imbalance	in	right	versus	left	fractures.		
Figure	2	shows	LOS	for	both	treatment	groups.	Mean	length	of	stay	was	1.79	±1.50	days	
in	the	tourniquet	group	and	1.65	±1.11	days	in	the	no‐tourniquet	group;	1.72	±1.32	days	
for	both	groups	combined.	Median	(interquartile	range	[IQR])	LOS	was	1.00	(1.00,	2.00)	
in	both	treatment	groups.	The	results	of	the	Poisson	regression	are	shown	in	Table	3	for	
the	primary	analysis	(ITT	adjusted)	and	the	sensitivity	analyses	(ITT	unadjusted,	and	as‐
treated).	The	 treatment	 effect	 shown	 is	 the	antilogged	coefficient	 from	 the	 regression	
model	 and	 represents	 a	 rate	 ratio,	with	 the	no	 tourniquet	 group	 as	 reference;	 a	 ratio	
greater	than	1	therefore	indicates	a	greater	LOS	with	use	of	a	tourniquet.		
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In	 the	 primary	 ITT	 analysis,	 there	 was	 a	 very	 small	 and	 statistically	 non‐significant	
difference	 in	 LOS;	 this	 was	 on	 average	 7.2%	 greater	 in	 the	 tourniquet	 group.	 The	
difference	in	LOS	was	much	smaller	than	the	1.5‐day	difference	considered	to	be	clinically	
important.	The	sensitivity	analysis	based	on	an	unadjusted	ITT	analysis	gave	a	similar	
non‐significant	result:	LOS	was	estimated	as	8.4%	greater	in	the	tourniquet	group.	In	the	
as‐treated	 sensitivity	 analysis,	 the	difference	was	 again	 small	 and	non‐significant,	 but	
favored	the	tourniquet	group:	LOS	was	on	average	3.8%	shorter	than	in	the	no‐tourniquet	
group.		
Figure	3	shows	mean	differences	 in	LOS	 from	the	adjusted	 ITT	analysis	by	subgroups	
defined	by	sex,	age	(18–50,	over	50),	Weber	classification	(B,	C)	and	ASA	grade	(1,	2,	3).	
The	estimates	 for	 the	Weber	classification	subgroups	were	very	similar	 to	 the	overall	
estimate.	Estimates	 for	male	patients	and	 those	over	50	appeared	 to	 favor	non‐use	of	
tourniquet,	 while	 those	 for	 female	 patients	 and	 those	 aged	 18–50	 appeared	 to	 favor	
tourniquet	use.	The	subgroups	defined	by	ASA	grade	show	some	variation,	but	it	should	
be	noted	that	there	are	only	5	patients	in	ASA	grade	3	and	the	estimate	for	this	subgroup	
is	therefore	very	imprecise	(as	indicated	by	the	very	wide	CI).	
The	 mean	 duration	 of	 the	 operative	 procedure	 was	 71.98	 ±25.54	 minutes	 for	 the	
tourniquet	group	and	76.37	±27.71	minutes	for	the	no‐tourniquet	group.	The	covariate‐
adjusted	mean	difference	in	the	ITT	analysis	(no	tourniquet	minus	tourniquet)	was	3.03	
minutes	(95%	CI	–4.96,	11.02;	p	=	.455).	The	unadjusted	ITT	mean	difference	was	4.39	
minutes	(95%	CI	–3.35,	12.12;	p	=	.264).	In	the	as‐treated	sensitivity	analysis,	the	mean	
duration	of	the	operative	procedure	was	73.11	±23.64	minutes	for	the	tourniquet	group	
(n	=	107)	and	76.58	±29.51	minutes	for	the	no‐tourniquet	group	(n	=	77).	The	covariate‐
adjusted	mean	difference	was	very	 similar	 to	 that	of	 the	 ITT	analysis	 at	2.35	minutes	
(95%	CI	–5.62,	10.31;	p	=	.562).	
Owing	to	the	small	effect	of	tourniquet	use	on	LOS,	an	additional	unplanned	analysis	was	
undertaken	to	determine	the	relative	effect	of	other	potential	predictors.	The	following	
variables,	 in	 addition	 to	 tourniquet	 use,	were	 entered	 in	 a	 Poisson	 regression	model,	
following	 a	 check	 for	 collinearity:	 age,	 BMI,	 time	 from	 fracture	 to	 surgery,	 time	 to	
operation,	 duration	 of	 operation,	 OMAS	 score,	 sex,	 Weber	 classification,	 ASA	 grade,	
regular	smoker,	mechanism	of	fracture	(see	Table	1	for	categorical	variable	values).	As	
these	represent	a	mixture	of	dichotomous,	multinomial	and	numeric	variables,	rate	ratios	
from	the	regression	analysis	are	not	comparable.	The	P	value	from	a	likelihood	ratio	test	
of	each	variable	was	therefore	used	as	an	indirect	index	of	its	strength	as	a	predictor	of	
LOS.	Table	3	gives	the	results	of	the	analysis.	Variables	are	presented	in	ascending	order	
of	their	associated	P	values,	and	hence	in	descending	order	of	predictive	strength.	ASA	
grade	(higher	grade	predicts	longer	LOS)	and	time	from	fracture	to	surgery	(shorter	time	
predicts	 longer	 LOS)	 were	 significant	 independent	 predictors.	 Ignoring	 statistical	
significance,	BMI,	age	and	duration	of	operation	were	additionally	stronger	predictors	
than	 tourniquet	 use.	 It	 should	 be	 noted	 that	 no	 sample	 size	 calculation	 had	 been	
performed	for	these	unplanned	analyses.	
Adverse	events	
Seven	 patients	 experienced	 intraoperative	 complications	 (Table	 4);	 2	 (2.2%)	 in	 the	
tourniquet	group	and	5	(5.4%)	in	the	no‐tourniquet	group	(odds	ratio	with	no	tourniquet	
as	 reference	 category	0.396	 (95%	CI	0.075,	 2.093);	p	=	 .444,	 Fisher’s	 exact	 test).	One	
patient	experienced	severe	pain	postoperatively,	when	a	cast	was	applied	(an	alternative	
cast	 was	 subsequently	 applied);	 this	 was	 considered	 to	 be	 unrelated	 to	 the	 study	
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interventions.	No	patients	required	admission	to	an	intensive	care	unit,	and	none	were	
readmitted	 for	 further	 surgery	 on	 the	 affected	 ankle.	 There	was	 one	 serious	 adverse	
event.	A	patient	in	the	no‐tourniquet	group	required	prolonged	hospitalization	following	
desaturation	 in	 the	 recovery	 room;	 this	was	 considered	 to	 be	 unrelated	 to	 the	 study	
interventions.	
	
Discussion	
The	 non‐use	 of	 a	 tourniquet	 did	 not	 produce	 a	 statistically	 significant	 or	 clinically	
important	difference	in	the	primary	outcome	measure,	and	this	study	did	not	therefore	
confirm	previous	evidence	that	use	of	a	tourniquet	increases	length	of	stay	[5–7].	In	the	
exploratory	analysis,	 the	only	2	variables	 that	significantly	affected	LOS	were	 the	ASA	
grade,	which	is	a	measure	of	pre‐existing	health	before	the	ankle	injury	has	occurred,	and	
time	from	fracture	to	surgery.	Those	patients	with	an	ASA	grade	of	1	had	a	mean	hospital	
LOS	of	1.35	days	and	those	with	an	ASA	2	had	a	mean	hospital	LOS	of	2.24	days.	60%	of	
patients	were	ASA	grade	1	and	35.5%	of	patients	were	ASA	grade	2.	Those	patients	with	
a	shorter	time	from	fracture	to	surgery	had	a	longer	LOS.	The	reason	for	this	is	unclear	
from	our	data.	
The	mean	overall	length	of	stay	in	our	study	of	1.72	days	was	considerably	shorter	than	
the	mean	of	4.38	days	in	the	preliminary	data	that	we	had	collected,	and	shorter	than	the	
mean	3.50	and	4.50	days	of	postoperative	stay	reported,	respectively,	by	Lloyd	et	al	[15]	
and	Singh	et	al	[16].	Consequently,	the	targeted	reduction	in	length	of	stay	of	1.5	days	
appeared	to	be	unrealistic.	It	is	not	clear	why	length	of	stay	was	so	much	shorter	in	our	
study.	It	does	not	appear	to	reflect	the	decision	to	assess	length	of	stay	in	terms	of	medical	
fitness	for	discharge,	as	the	mean	length	of	stay	until	actual	discharge	was	similar,	at	1.99	
days.	Instead,	it	may	reflect	changes	in	practice	within	the	participating	hospitals	since	
the	preliminary	data	were	collected.	
It	has	recently	been	reported	that	patients	who	have	surgery	for	closed	ankle	fractures	
within	24	hours	of	injury	have	shorter	length	of	stay	than	those	operated	on	later	[16].	
Our	data	do	not	confirm	this.	The	mean	length	of	stay	for	those	operated	on	within	24	
hours	(1.89	days;	n	=	46)	was	greater	than	that	for	those	operated	on	later	(1.66	days;	n	
=	142).	
There	was	a	higher	rate	of	protocol	deviation	in	the	no‐tourniquet	group	(a	tourniquet	
was	 used	 for	 19	 patients)	 than	 in	 the	 tourniquet	 group	 (only	 3	 patients	 had	 no	
tourniquet).	This	may	reflect	the	surgeon’s	personal	preference	for	use	of	a	tourniquet	to	
provide	a	bloodless	field.	The	as‐treated	analysis,	which	reflects	this	protocol	deviation,	
showed	 LOS	 to	 be	 slightly	 shorter	 with	 tourniquet	 use,	 but	 the	 difference	 is	 non‐
significant.	Confirming	previous	 findings	 [5],	 tourniquet	use	did	not	have	a	significant	
effect	on	operative	time,	although	duration	of	operation	was	slightly	shorter	in	the	non‐
tourniquet	group	than	in	the	tourniquet	group	(72.34	vs	76.37	minutes).	
The	strengths	of	our	study	include	the	fact	that	we	have	a	complete	set	of	data	on	length	
of	stay	and	on	operation	time	for	patients	undergoing	surgery,	and	statistical	analysis	was	
blinded,	 allowing	 us	 to	 reach	 unbiased	 conclusions	 regarding	 LOS.	 All	 staff	 assessing	
patients’	fitness	for	discharge	were	blinded	to	tourniquet	use,	reducing	the	risk	of	bias	in	
clinical	 decision	 making.	 Broad	 inclusion	 criteria	 assist	 the	 generalizability	 of	 our	
findings.		The	availability	of	other	medical	data,	including	ASA	grade,	time	from	injury	to	
surgery	has	allowed	us	to	perform	further	exploratory	statistical	analysis	on	other	factors	
that	affect	length	of	stay,	though	as	these	were	unplanned	analyses	for	which	the	study	
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was	 not	 specifically	 powered,	 they	 must	 be	 interpreted	 with	 caution.	 Similarly,	 the	
subgroup	analyses	were	exploratory	and	should	be	interpreted	accordingly.	The	high	rate	
of	protocol	deviation	in	the	no‐tourniquet	group	suggests,	 in	some	instances,	a	 lack	of	
clinical	 equipoise,	 though	 the	 as‐treated	 analysis	 indicates	 this	 is	 unlikely	 to	 have	
seriously	biased	the	statistical	comparisons.	
In	 conclusion,	 our	 study	 has	 demonstrated	 that	 hospital	 LOS	 following	 operative	
management	 of	 closed	 ankle	 fractures	 in	 skeletally	mature	 adults	 is	 not	 significantly	
affected	by	the	use	of	a	tourniquet	during	surgery.	Pre‐injury	medical	condition	of	the	
patient	 appeared	 to	 be	 the	 single	 most	 influential	 factor	 identified	 affecting	 hospital	
length	of	stay.	 	 	 	
	
	
	 Tourniquet	
(n	=	94)	
No	tourniquet	
(n	=	94)	
Age	(years);	mean	±SD	 48.36	±14.33	 48.34	±17.24	
BMI;	mean	±SD	a	 29.50	±6.47	 28.39	±6.43	
Sex;	n	(%)		 male	 41	(44)	 35	(37)	
female	 53	(56)	 59	(63)	
Regular	smoker	 yes	 26	(28)	 22	(23)	
no	 68	(72)	 72	(77)	
Affected	ankle;	n	
(%)	
left	 54	(57)	 37	(39)	
right	 40	(43)	 57	(61)	
Mechanism	of	
fracture;	n	(%)	
low	energy	 80	(85)	 82	(87)	
high	energy	 12	(13)	 8	(9)	
crush	injury	 1	(1)	 2	(2)	
other	 1	(1)	 2	(2)	
ASA	grade;	n	(%)	 1	 55	(59)	 55	(59)	
2	 35	(37)	 38	(40)	
3	 4	(4)	 1	(1)	
Weber	
classification;	n	(%)	
A	 0	(0)	 0	(0)	
B	 75	(80)	 62	(66)	
C	 19	(20)	 32	(34)	
Centre;	n	(%)	 Stoke	 83	(88)	 82	(87)	
Cambridge	 9	(10)	 9	(10)	
Telford	 2	(2)	 3	(3)	
Time	between	fracture	and	
surgery;	mean	±	SD	b		
6.14	±3.66	 5.22	±3.64	
OMAS	total	score;	mean	±SD	c	 98.09	±5.87	 97.90	±7.20	
a	19	missing	values,	n1=86,	n2=83;	b	3	patients	did	not	receive	surgery,	so	time	to	operation	
calculated	in	terms	of	when	surgery	was	scheduled;	c	1	missing	value;	n1=94,	n2=93;	OMAS	=	
Olerud	Molander	Ankle	Scale.	
	
Table	1.	Baseline	characteristics	(N	=	186).	
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Analysis	 Tourniquet	(mean;	days)	
No	
tourniquet	
(mean;	days)	
Effect	
(rate	
ratio)	a	
95%	confidence	
interval	
p	
value	
Primary:	 	 	 	 	 	
ITT	analysis,	
adjusted	b		 1.74	 1.62	 1.072	 0.854,	1.346	 .549	
Sensitivity:	 	 	 	 	 	
ITT	analysis,	
unadjusted		 1.79	 1.65	 1.084	 0.871,	1.348	 .470	
As‐treated	analysis,	
adjusted	b,	c	 1.65	 1.71	 0.962	 0.764,	1.212	 .744	
a	Reference	group	is	no	tourniquet;	b	Adjusted	for	Weber	classification,	sex,	BMI,	treatment	
center,	time	from	fracture	to	surgery,	sex,	and	age;	c	based	on	n=107	and	n=77	for	tourniquet	
and	no‐tourniquet	groups	respectively.	
Table	2.	Results	of	the	Poisson	regression	analysis	on	length	of	stay	(N	=	186).	
	
Predictor	
Likelihood	
ratio	chi‐
square	
Degrees	of	
freedom	 p	value	
ASA	grade	 10.571	 2	 .005	
Time	from	fracture	to	surgery	 4.996	 1	 .025	
BMI	 3.024	 1	 .082	
Age	 .879	 1	 .349	
Duration	of	operation	 .826	 1	 .363	
Tourniquet	use	 .806	 1	 .369	
Sex	 .507	 1	 .476	
Weber	classification	 .068	 1	 .795	
Mechanism	of	fracture	 .826	 3	 .843	
Regular	smoker	 .015	 1	 .904	
OMAS	score	 <.001	 1	 .999	
Table	3.	Predictors	of	length	of	stay	(N	=	169).	
	
Complication	
Tourniquet	
group	(n	=	91)	
No‐tourniquet	
group	(n	=	93)	
Vascular	injury	 0	 1	
Blood	loss	(250	ml)	 0	 1	
Aspiration	 0	 1	
Drill	bit	snapped	 1	 1	
Other	equipment/staff	issues	 1	 1	
Table	4.	Intraoperative	complications	in	patients	undergoing	surgery	(N	=	184).	
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Figure	1.	CONSORT	diagram	showing	the	progression	of	patients	through	the	trial.	
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Figure	2.	Length	of	stay	in	the	tourniquet	and	no‐tourniquet	groups.	
	
Figure	3.	Length	of	stay	for	subgroups.	Figures	are	mean	difference	in	days	(tourniquet	
group	minus	no‐tourniquet	group)	with	95%	confidence	intervals.	Negative	differences	
favor	the	tourniquet	group;	positive	differences	favor	the	no‐tourniquet	group.	The	
solid	vertical	reference	line	indicates	the	overall	mean	difference.	The	dashed	vertical	
reference	line	indicates	a	mean	difference	of	zero.	
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